{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:40:22Z","timestamp":1790743222561,"version":"4.1.0"},"reference-count":44,"publisher":"FapUNIFESP (SciELO)","issue":"suppl 1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.66.s1.10","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T14:51:36Z","timestamp":1578927096000},"page":"s10-s16","source":"Crossref","is-referenced-by-count":65,"title":["Fabry disease: genetics, pathology, and treatment"],"prefix":"10.1590","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-0859","authenticated-orcid":false,"given":"Tha\u00edza Passaglia","family":"Bernardes","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9370-0265","authenticated-orcid":false,"given":"Renato Demarchi","family":"Foresto","sequence":"additional","affiliation":[{"name":"Hospital do Rim, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-4109","authenticated-orcid":false,"given":"Gianna Mastroianni","family":"Kirsztajn","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2020]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain DP","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course","volume":"812","author":"Branton MH","year":"2002","journal-title":"Medicine Baltimore)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Fabry Registry. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"932","author":"Wilcox WR","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"645","author":"Hopkin RJ","year":"2008","journal-title":"Pediatr Res"},{"key":"ref5","first-page":"113","article-title":"A case of \u201cangiokeratoma\u201d","volume":"10","author":"Anderson W","year":"1898","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01986897","article-title":"Ein beitragzur kenntnis der Purpura haemorrhagica nodularis Purpura papulosa haemorrhagica Hebrae)","volume":"43","author":"Fabry J","year":"1898","journal-title":"Arch Dermatol Syphilis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0954-6820.1947.tb06596.x","article-title":"Angiokeratoma corporis diffusum universale) Fabry, as a sign of an unknown internal disease: two autopsy reports","volume":"1283","author":"Pompen AW","year":"1947","journal-title":"Acta Med Scand"},{"key":"ref8","first-page":"23","article-title":"Doen\u00e7a de Fabry","volume":"41","author":"Silva CAB","year":"2017","journal-title":"Rev Med UFPR"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"2813","author":"Meikle PJ","year":"1999","journal-title":"JAMA"},{"key":"ref10","first-page":"1004","article-title":"Fabry disease: a diagnostic and therapeutic challenge","volume":"1258","author":"Houge G","year":"2005","journal-title":"Tidsskr Nor Laegeforen"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"791","author":"Spada M","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A IVS4+919G>A)","volume":"3010","author":"Hwu WL","year":"2009","journal-title":"Hum Mutat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10157-005-0369-4","article-title":"Significance of screening for Fabry disease among male dialysis patients","volume":"93","author":"Ichinose M","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"ref14","first-page":"235","article-title":"Preval\u00eancia da doen\u00e7a de Fabry em pacientes portadores de doen\u00e7a renal cr\u00f4nica submetidos \u00e0 hemodi\u00e1lise em Natal \u2013 RN","volume":"294","author":"Marinho LAL","year":"2007","journal-title":"J Bras Nefrol"},{"key":"ref15","first-page":"259","article-title":"Diagn\u00f3stico de doen\u00e7a de Fabry em indiv\u00edduos submetidos \u00e0 hemodi\u00e1lise no estado do Piau\u00ed: o papel do exame de triagem e estudo de casos","volume":"304","author":"Vale NFD","year":"2008","journal-title":"J Bras Nefrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/08860220802353777","article-title":"Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report","volume":"309","author":"Porsch DB","year":"2008","journal-title":"Ren Fail"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000448740","article-title":"Targeted screening of Fabry disease in male hemodialysis patients in Brazil highlights importance of family screening","volume":"1344","author":"Silva CA","year":"2016","journal-title":"Nephron"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<420::AID-AJMG6>3.0.CO;2-Z","article-title":"Fabry disease: comparison of enzymatic, linkage and mutation analysis for carrier detection in a family with a novel mutation 30delG)","volume":"845","author":"Asthon-Prolla P","year":"1999","journal-title":"Am J Med Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<436::AID-AJMG14>3.0.CO;2-X","article-title":"Different phenotypic expression in relatives with Fabry disease caused by a W226X mutation","volume":"825","author":"Knol IE","year":"1999","journal-title":"Am J Med Genet"},{"key":"ref20","article-title":"Fabry disease due to D313Y and novel GLA mutations","volume":"710","author":"Koulousios K","year":"2017","journal-title":"BMJ Open"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003495-200767030-00007","article-title":"Agalsidase Beta: a review of its use in the management of Fabry disease","volume":"673","author":"Keating GM","year":"2007","journal-title":"Drugs"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Algasidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"1462","author":"Banikazemi M","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08035320600618809","article-title":"Disease manifestations and X inactivation in heterozygous females with Fabry disease","volume":"95451","author":"Maier EM","year":"2006","journal-title":"Acta Paediatr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00401-005-0026-8","article-title":"Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients","volume":"1112","author":"Navarro C","year":"2006","journal-title":"Acta Neuropathol"},{"key":"ref25","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3733","volume-title":"a-Galactosidase A deficiency: Fabry disease","author":"Desnick RJ","year":"2001","edition":"8th ed."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08035320600618825","article-title":"The Mainz Severity Score Index MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease","volume":"95451","author":"Beck M","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.7326\/0003-4819-146-2-200701160-00147","article-title":"Enzyme replacement in Fabry disease: the essence is in the kidney","volume":"1462","author":"Schiffmann R","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/jmedgenet-2015-103471","article-title":"Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy","volume":"5212","author":"Warnock DG","year":"2015","journal-title":"J Med Genet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"s134","DOI":"10.1097\/01.ASN.0000016684.07368.75","article-title":"Renal pathology in Fabry disease","volume":"13","author":"Alroy J","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref30","first-page":"245","article-title":"Acometimento renal na doen\u00e7a de Fabry","volume":"382","author":"Abensur H","year":"2016","journal-title":"J Bras Nefrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/oxfordjournals.ndt.a027338","article-title":"Is there true recurrence of Fabry's disease in the transplanted kidney?","volume":"113","author":"Peces R","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"ref32","series-title":"Fabry disease: perspectives from 5 years of FOS","first-page":"315","volume-title":"Measurement of disease severity and progression in Fabry disease","author":"Whybra C","year":"2006"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"s130","DOI":"10.1097\/01.ASN.0000015236.70757.C4","article-title":"Biochemical and molecular genetic basis of Fabry disease","volume":"13","author":"Pastores GM","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","article-title":"Plasma globotriaosylsphingosine as a biomarker of Fabry disease","volume":"1003","author":"Togawa T","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/08860220500244856","article-title":"Fabry disease: a diagnostic and therapeutic problem","volume":"276","author":"Strujic BJ","year":"2005","journal-title":"Ren Fail"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2016.10.006","article-title":"Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes","volume":"1201","author":"Nowak A","year":"2017","journal-title":"Mol Genet Metab"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbadis.2010.09.007","article-title":"Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy","volume":"18121","author":"van Breemen MJ","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"654","author":"Whybra C","year":"2004","journal-title":"Clin Genet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"1384","author":"Desnick RJ","year":"2003","journal-title":"Ann Int Med"},{"key":"ref40","article-title":"Enzyme replacement therapy for Anderson-Fabry disease","volume":"7","author":"El Dib R","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nrg963","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"312","author":"Desnick RJ","year":"2002","journal-title":"Nat Rev Genet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"C1076","DOI":"10.1152\/ajpcell.00426.2005","article-title":"Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants","volume":"2904","author":"Yam GH","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref43","article-title":"Oral Migalastat HCl leads to greater systemic exposure and tissue levels of active \u03b1-galactosidase A in Fabry patients when co- administered with infused agalsidase","volume":"108","author":"Warnock DG","year":"2015","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1012455421014","article-title":"Gene therapy for Fabry disease","volume":"24","author":"Siatskas C","year":"2001","journal-title":"J Inherit Metab Dis"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v66s1\/1806-9282-ramb-66-s1-s10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T22:06:10Z","timestamp":1722290770000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302020001300010&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":44,"journal-issue":{"issue":"suppl 1","published-online":{"date-parts":[[2020]]}},"alternative-id":["S0104-42302020001300010"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.66.s1.10","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}